Insomnia Market Size, Surging Demand, Detailed Analysis, Share And Forecast To 2033

The new report published by The Business Research Company, titled Insomnia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the insomnia market size has grown strongly in recent years. It will grow from $4.72 billion in 2023 to $4.97 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The insomnia market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp

Rise In Work Related Stress To Drive Market Growth
The surge in work-related Stress is expected to propel the growth of the insomnia market going forward. Work-related Stress refers to harmful emotional and physical responses that occur when the work demands, and pressures do not match the worker's resources, capabilities, or knowledge. Job stress can lead to poor health, including insomnia. Depending on the severity of insomnia, the patients are treated with drug or cognitive-behavioral therapies, among others. Thus, the surge in work-related Stress is boosting sales in the insomnia market. For instance, in October 2021, according to a survey of 1,500 US employees conducted by the American Psychology Association, a US-based professional organization of psychologists, approximately 59% of the respondents were experiencing work-related stress in 2021. Furthermore, in November 2022, according to the US Bureau of Labor Statistics, a US-based principal fact-finding agency of the US government, the total rate of injuries increased in 2021 to 2.3 cases per 100 full-time equivalent workers, up from 2.2 cases in 2020. Real-reported injuries in 2021 increased by 6.3% (2.2 million cases) compared to 2020 (2.1 million cases). Therefore, the surge in work-related Stress is driving the growth of the insomnia market.

Revolutionizing Insomnia Therapeutics With Innovative Digital Treatment Device
Product innovation is the key trend gaining popularity in the insomnia market. Major companies operating in the insomnia therapeutics market are developing innovative treatments to sustain their position in the market. For instance, in April 2023, WELT, a Korea-based medical device company, received approval from the Ministry of Food and Drug Safety (MFDS) for its digital insomnia treatment device, WELT-I. WELT-I was designated as an innovative medical aimed at correcting behavioral, psychological, and cognitive factors that sustain or worsen insomnia. The device delivers treatment based on cognitive behavioral therapy (CBT) as a first-line treatment in clinical guidelines for insomnia. The device is classified as a software as a medical device (SaMD), improving insomnia by performing personalized sleep time, analyzing sleep disturbance habits, intervening in patient behavior to enhance sleep quality, and delivering relaxation therapy for eight weeks to reduce tension and anxiety.

The insomnia market covered in this report is segmented -

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy
2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12120&type=discount

Major companies operating in the insomnia market report are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Contents of the report:
1. Executive Summary
2. Insomnia Market Report Structure
3. Insomnia Market Trends And Strategies
4. Insomnia Market - Macro Economic Scenario
5. Insomnia Market Size And Growth
…..
27. Insomnia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.